These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center. Adrianzen Herrera D; Kornblum N; Acuna-Villaorduna A; Sica RA; Shah U; Butler M; Vishnuvardhan N; Shah N; Bachier-Rodriguez L; Derman O; Shastri A; Mantzaris I; Verma AK; Braunschweig I; Janakiram M Biol Blood Marrow Transplant; 2019 Jun; 25(6):e199-e203. PubMed ID: 30769194 [TBL] [Abstract][Full Text] [Related]
45. [Adult T cell lymphoblastic leukemia/lymphoma by HTLV-1 in a young woman]. Delgado S; Gotuzzo E Rev Chilena Infectol; 2019 Apr; 36(2):234-237. PubMed ID: 31344159 [TBL] [Abstract][Full Text] [Related]
51. Adult T-cell leukemia/lymphoma in a Peruvian hospital in human T-lymphotropic virus type 1 (HTLV-1) positive patients. Rodríguez-Zúñiga MJ; Cortez-Franco F; Qujiano-Gomero E Int J Dermatol; 2017 May; 56(5):503-509. PubMed ID: 28251608 [TBL] [Abstract][Full Text] [Related]
52. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Yamada Y; Tomonaga M Leuk Lymphoma; 2003 Apr; 44(4):611-8. PubMed ID: 12769337 [TBL] [Abstract][Full Text] [Related]
53. [Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1)]. Nobre V; Guedes AC; Proietti FA; Stanciolli E; Martins ML; Serufo JC; Antunes CM; Grossi MA; Lambertucci JR; Rev Soc Bras Med Trop; 2005; 38(1):43-52. PubMed ID: 15717094 [TBL] [Abstract][Full Text] [Related]
54. Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence. Bittencourt AL; Primo J; Oliveira MF J Pediatr (Rio J); 2006; 82(6):411-20. PubMed ID: 17171202 [TBL] [Abstract][Full Text] [Related]
55. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Tanosaki R; Uike N; Utsunomiya A; Saburi Y; Masuda M; Tomonaga M; Eto T; Hidaka M; Harada M; Choi I; Yamanaka T; Kannagi M; Matsuoka M; Okamura J Biol Blood Marrow Transplant; 2008 Jun; 14(6):702-8. PubMed ID: 18489996 [TBL] [Abstract][Full Text] [Related]
56. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Banerjee P; Tripp A; Lairmore MD; Crawford L; Sieburg M; Ramos JC; Harrington W; Beilke MA; Feuer G Blood; 2010 Apr; 115(13):2640-8. PubMed ID: 20124219 [TBL] [Abstract][Full Text] [Related]
57. Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma. O'Donnell JS; Hunt SK; Chappell KJ Lancet Haematol; 2023 Jul; 10(7):e539-e548. PubMed ID: 37407143 [TBL] [Abstract][Full Text] [Related]